Multivalent fowl Adenovirus-Newcastle disease vaccine: comprehensive evaluation in SPF and commercial broiler breeders
Veterinary Research Communications · 2026
DOI: 10.1007/s11259-026-11068-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Research Communications, 2026. Verfasst von Nahed Yahia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute, Agriculture Research Centre (ARC)…. Hauptthemen laut MEDLINE: Chickens, Viral Vaccines, Newcastle Disease, Newcastle disease virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Inclusion body hepatitis (IBH) and Newcastle disease (ND) impose substantial economic burdens on global poultry production, with combined annual losses exceeding $3 billion worldwide. Current vaccination strategies requiring separate immunizations increase handling stress and operational costs. OBJECTIVE: To evaluate immunogenicity, cross-neutralization patterns, protective efficacy against virulent challenge, maternal antibody transfer, and commercial field performance of a novel multivalent inactivated vaccine containing fowl adenovirus (FAdV) serotypes 2, 8a, 8b, and 11 combined with Newcastle disease virus (NDV). METHODS: Two randomized, blinded, placebo-controlled trials were conducted: SPF trial (n = 200, Egypt) and commercial field trial (n = 120,000, Saudi Arabia). The multivalent vaccine contained inactivated FAdV serotypes 2, 8a, 8b, and 11 plus NDV strains, administered at 10 and 16 weeks of age with 24-week monitoring. RESULTS: Vaccination induced robust antibody responses with FAdV ELISA geometric mean titers (GMT) reaching 22,847 (95% CI: 18,245 - 28,589) at weeks 4-6 post-primary vaccination, with peak anamnestic response of 28,945 (95% CI: 23,186 - 36,115) at week 8 following booster (p < 0.001) and NDV hemagglutination inhibition titers of 9.8 log₂ (95% CI: 8.4-11.4) (p < 0.001). Challenge studies demonstrated 96.7% protection against FAdV-2 (species D) (29/30 vaccinated vs. 6/30 controls; Fisher's exact p < 0.0001) and 100% protection against NDV (30/30 vs. 0/30). Maternal antibody transfer efficiency was 68.6% for IBH and 81.7% for NDV, with half-lives of 4.2 and 4.8 days respectively, providing 24-28 days and 21-24 days protection in progeny. Commercial field trial (120,000 birds) demonstrated 94.2% reduction in IBH mortality with 3.47:1 return on investment. CONCLUSIONS: The multivalent IBH-NDV vaccine provides comprehensive immunological protection and consistent field efficacy. Although the cross-neutralization assay included representative serotypes, broader testing across additional field isolates is warranted to further define cross-protective breadth. Cross-neutralization analysis confirms the necessity of multivalent formulations due to type-specific immunity patterns, supporting implementation for integrated disease control in commercial broiler operations. This study provides a detailed evaluation of a quadrivalent FAdV-NDV inactivated vaccine demonstrating efficient maternal antibody transfer in broiler breeders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute, Agriculture Research Centre (ARC), Giza, 12618, Egypt.
- Klybeck Life Science Company, Dammam , 34848, Kingdom of Saudi Arabia.
- Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, 12622, Egypt.
- Texas Biomedical Research Institute, Texas, San Antonio, TX 78245-0549, USA.
- Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
- Veterinary Serum and Vaccine Research Institute, Agricultural Research Center (ARC), Abbasia, Cairo, 11381, Egypt. ahme2001@gmail.com.
Zitieren
APA
Yahia, N., Abdelhalim, A., Mahmoud, S. H., Bazid, A., Kumar, R., Aljassas, H., Alhnout, M., Alhassan, D., Hussien, H. A., Eid, S., & Khalil, A. A. (2026). Multivalent fowl Adenovirus-Newcastle disease vaccine: comprehensive evaluation in SPF and commercial broiler breeders. Veterinary Research Communications. https://doi.org/10.1007/s11259-026-11068-9
Vancouver
Yahia N, Abdelhalim A, Mahmoud SH, Bazid A, Kumar R, Aljassas H, et al. Multivalent fowl Adenovirus-Newcastle disease vaccine: comprehensive evaluation in SPF and commercial broiler breeders. Veterinary Research Communications. 2026. doi:10.1007/s11259-026-11068-9
BibTeX
@article{Yahia2026,
author = {Yahia, Nahed and Abdelhalim, Ahmed and Mahmoud, Sara Hussein and Bazid, Abdelhamid and Kumar, Ravi and Aljassas, Hussein and Alhnout, Maryam and Alhassan, Dana and Hussien, Hussien Ali and Eid, Samah and Khalil, Ahmed Aly},
title = {Multivalent fowl Adenovirus-Newcastle disease vaccine: comprehensive evaluation in SPF and commercial broiler breeders},
journal = {Veterinary Research Communications},
year = {2026},
doi = {10.1007/s11259-026-11068-9}
}
EUVIMED